Lymphopenia-induced proliferation is a potent activator for CD4+ T cell-mediated autoimmune disease in the retina

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 969-979

  McPherson, Scott W ^a   Heuss, Neal D ^a   Gregerson, Dale S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETINA CELL; RETINA DISEASE; TRANSGENIC MOUSE; UVEORETINITIS; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; CELL CULTURE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; RETINITIS; TRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; BETA-GALACTOSIDASE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETINITIS;

EID: 60549102353     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.969     Document Type: Article

References (54)

1. Carson, M. J., J. M. Doose, B. Melchior, C. D. Schmid, and C. C. Ploix. 2006. CNS immune privilege: hiding in plain sight. Immunol. Rev. 213: 48-65.
2. Cserr, H. F., C. J. Harling-Berg, and P. M. Knopf. 1992. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 2: 269-276.
3. Yamada, S., M. DePasquale, S. C. Patlak, and H. F. Cserr. 1991. Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am. J. Physiol. 261: H1197-H1204.
4. Anderson, M. S., E. S. Venanzi, L. Klein, Z. Chen, S. Berzins, S. J. Turley, H. Von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis. 2002. Projection of an immunological self-shadow within the thymus by the aire protein. Science 298: 1395-1401.
5. DeVoss, J., Y. Hou, K. Johannes, W. Lu, G. I. Liou, J. Rinn, H. Chang, R. Caspi, L. Fong, and M. S. Anderson. 2006. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J. Exp. Med. 203: 2727-2735.
6. Egwuagu, C. E., P. Charukamnoetkanok, and I. Gery. 1997. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159: 3109-3112.
7. McPherson, S. W., and D. S. Gregerson. 1994. Nucleotide sequences homologous to retinal S-antigen in the rat thymus lack a known EAU inducing epitope. In Sixth International Symposium on the Immunology and Immunopathology of the Eye. R. B. Nussenblatt, S. M. Whitcup, R. R. Caspi, and I. Gery, eds. Elsevier Sciences, Bethesda, MD, pp. 67-70.
8. Avichezer, D., R. S. Grajewski, C. C. Chan, M. J. Mattapallil, P. B. Silver, J. A. Raber, G. I. Liou, B. Wiggert, G. M. Lewis, L. A. Donoso, and R. R. Caspi. 2003. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med. 198: 1665-1676.
9. Ham, D. I., S. J. Kim, J. Chen, B. P. Vistica, R. N. Fariss, R. S. Lee, E. F. Wawrousek, H. Takase, C. R. Yu, C. E. Egwuagu, et al. 2004. Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter. Invest. Ophthalmol. Visual Sci. 45: 857-862.
10. Lambe, T., J. C. Leung, H. Ferry, T. Bouriez-Jones, K. Makinen, T. L. Crockford, H. R. Jiang, J. M. Nickerson, L. Peltonen, J. V. Forrester, and R. J. Cornall. 2007. Limited peripheral T cell anergy predisposes to retinal autoimmunity. J. Immunol. 178: 4276-4283.
11. + regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med. 203: 851-856.
12. Fling, S. P., L. A. Donoso, and D. S. Gregerson. 1991. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J. Immunol. 147: 483-489.
13. Gregerson, D. S. 2002. Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity. Int. Rev. Immunol. 21: 101-121.
14. high) CD4 T cells to recognize their target antigen in retina. J. Neuroimmunol. 120: 34-41.
15. Agarwal, R. K., Y. Kang, E. Zambidis, D. W. Scott, C. C. Chan, and R. R. Caspi. 2000. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. [See comments.] J. Clin. Invest. 106: 245-252.
16. McPherson, S. W., J. P. Roberts, and D. S. Gregerson. 1999. Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis. J. Immunol. 163: 4269-4276.
17. Xu, H., E. F. Wawrousek, T. M. Redmond, J. M. Nickerson, B. Wiggert, C. C. Chan, and R. R. Caspi. 2000. Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. Eur. J. Immunol. 30: 272-278.
18. Silver, P. B., R. K. Agarwal, S. B. Su, I. Suffia, R. S. Grajewski, D. Luger, C. C. Chan, R. M. Mahdi, J. M. Nickerson, and R. R. Caspi. 2007. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J. Immunol. 179: 5146-5158.
19. Gregerson, D. S., J. W. Torseth, S. W. McPherson, J. P. Roberts, T. Shinohara, and D. J. Zack. 1999. Retinal expression of a neo-self antigen, β-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J. Immunol. 163: 1073-1080.
20. Gregerson, D. S., and C. Dou. 2002. Spontaneous induction of immunoregulation by an endogenous retinal antigen. Invest. Ophthalmol. Visual Sci. 43: 2984-2991.
21. McPherson, S. W., J. Yang, C. C. Chan, C. Dou, and D. S. Gregerson. 2003. Resting CD8 T cells recognize β-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. Immunology 110: 386-396.
22. Kimura, A., D. Singh, E. F. Wawrousek, M. Kikuchi, M. Nakamura, and T. Shinohara. 2000. Both PCE-1/RX and OTX/CRX interactions are necessary for photoreceptor- specific gene expression. J. Biol. Chem. 275: 1152-1160.
23. Kikuchi, T., K. Raju, M. L. Breitman, and T. Shinohara. 1993. The proximal promoter of the mouse arrestin gene directs gene expression in photoreceptor cells and contains an evolutionarily conserved retinal factor-binding site. Mol. Cell. Biol. 13: 4400-4408.
24. Johnson, W. B., M. D. Ruppe, E. M. Rockenstein, J. Price, V. P. Sarthy, L. C. Verderber, and L. Mucke. 1995. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes. Glia 13: 174-184.
25. Gregerson, D. S., W. F. Obritsch, and L. A. Donoso. 1993. Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J. Immunol. 151: 5751-5761.
26. McPherson, S. W., N. D. Heuss, H. Roehrich, and D. S. Gregerson. 2006. Bystander killing of neurons by cytotoxic T cells specific for a glial antigen. Glia 53: 457-466.
27. Caspi, R. R. 2002. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int. Rev. Immunol. 21: 197-208.
28. McPherson, S. W., J. P. Roberts, and D. S. Gregerson. 2005. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis. Curr. Eye Res. 30: 491-502.
29. Tang, J., W. Zhu, P. B. Silver, S. B. Su, C. C. Chan, and R. R. Caspi. 2007. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J. Immunol. 178: 5578-5587.
30. + interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Visual Sci. 48: 4153-4161.
31. Lafaille, J. J. 2004. T-cell receptor transgenic mice in the study of autoimmune diseases. J. Autoimmun. 22: 95-106.
32. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560.
33. Caspi, R. R., P. B. Silver, C. C. Chan, B. Sun, R. K. Agarwal, J. Wells, S. Oddo, Y. Fujino, F. Najafian, and R. L. Wilder. 1996. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J. Immunol. 157: 2668-2675.
34. Amadi-Obi, A., C. R. Yu, X. Liu, R. M. Mahdi, G. L. Clarke, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718.
35. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6: 169-175.
36. Dick, A. D., J. V. Forrester, J. Liversidge, and A. P. Cope. 2004. The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU). Prog. Retin. Eye Res. 23: 617-637.
37. Su, S. B., R. S. Grajewski, D. Luger, R. K. Agarwal, P. B. Silver, J. Tang, J. Tuo, C. C. Chan, and R. R. Caspi. 2007. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-γ deficiency. Invest. Ophthalmol. Visual Sci. 48: 4616-4625.
38. Fujimoto, C., C. R. Yu, G. Shi, B. P. Vistica, E. F. Wawrousek, D. M. Klinman, C. C. Chan, C. E. Egwuagu, and I. Gery. 2006. Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J. Immunol. 177: 6896-6903.
39. Krupica, T., Jr., T. J. Fry, and C. L. Mackall. 2006. Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 120: 121-128.
40. Knoechel, B., J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202: 1375-1386.
41. Abbas, A. K., J. Lohr, and B. Knoechel. 2007. Balancing autoaggressive and protective T cell responses. J. Autoimmun. 28: 59-61.
42. Cabbage, S. E., E. S. Huseby, B. D. Sather, T. Brabb, D. Liggitt, and J. Goverman. 2007. Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance. J. Immunol. 178: 887-896.
43. Cao, Y., C. Toben, S. Y. Na, K. Stark, L. Nitschke, A. Peterson, R. Gold, A. Schimpl, and T. Hunig. 2006. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 36: 207-215.
44. Cabarrocas, J., E. Piaggio, J. P. Zappulla, S. Desbois, L. T. Mars, H. Lassmann, and R. S. Liblau. 2004. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J. Autoimmun. 22: 179-189.
45. Campagnoni, A. T., T. M. Pribyl, C. W. Campagnoni, K. Kampf, S. Amur-Umarjee, C. F. Landry, V. W. Handley, S. L. Newman, B. Garbay, and K. Kitamura. 1993. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J. Biol. Chem. 268: 4930-4938.
46. Pribyl, T. M., C. W. Campagnoni, K. Kampf, T. Kashima, V. W. Handley, J. McMahon, and A. T. Campagnoni. 1993. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc. Natl. Acad. Sci. USA 90: 10695-10699.
47. Clark, L., L. Otvos, Jr., P. L. Stein, X. M. Zhang, A. F. Skorupa, G. E. Lesh, F. A. McMorris, and E. Heber-Katz. 1999. Golli-induced paralysis: a study in anergy and disease. J. Immunol. 162: 4300-4310.
48. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187: 2055-2063.
49. + T cells maintain tolerance to myelin basic protein by "epitope theft." Nat. Immunol. 5: 606-614.
50. Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, and D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5: 1151-1158.
51. Maverakis, E., J. Beech, D. B. Stevens, A. Ametani, L. Brossay, P. van den Elzen, R. Mendoza, Q. Thai, L. H. Macias, D. Ethell, et al. 2003. Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC. Proc. Natl. Acad. Sci. USA 100: 5342-5347.
52. Xu, H., M. Chen, D. M. Reid, and J. V. Forrester. 2007. LYVE-1-positive macrophages are present in normal murine eyes. Invest. Ophthalmol. Visual Sci. 48: 2162-2171.
53. Hickey, W., B. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-260.
54. Prendergast, R. A., C. E. Iliff, N. M. Coskuncan, R. R. Caspi, G. Sartani, T. K. Tarrant, G. A. Lutty, and D. S. McLeod. 1998. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Visual Sci. 39: 754-762.